As of 3:59pm ET
| +0.28 / +2.76%|
The 4 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a -18.35% decrease from the last price of 10.41.
The current consensus among 5 polled investment analysts is to Buy stock in Pacific Biosciences of California Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.